Functional genomic methods to study estrogen receptor activity

Siv Gilfillan1, Elisa Fiorito, Antoni Hurtado

  • 1Breast Cancer Research group, Nordic EMBL Partnership, Centre for Molecular Medicine Norway, University of Oslo, Blindern, Oslo, Norway.

Insights

Estrogen Receptor (ER) research reveals how estrogen and tamoxifen impact breast cancer genomics. Functional genomic methods like ChIP and FAIRE help analyze these ER-ligand interactions and chromatin changes.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Estrogen Receptor (ER) is crucial in mediating estrogen and tamoxifen actions.
  • ER is frequently expressed in human breast cancers.
  • Genomic mapping of ER interactions with estrogen and tamoxifen has recently been established.

Purpose of the Study:

  • To review functional genomic methods for studying ER ligand and co-operating factor influences.
  • To explore methods analyzing protein-DNA interactions and chromatin modifications.
  • To understand ER transcriptional regulation in breast cancer.

Main Methods:

  • Chromatin Immunoprecipitation (ChIP) for protein-DNA interactions.
  • Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE) for chromatin accessibility.
  • Integration of these methods with high-throughput sequencing.

Main Results:

  • Estrogen and tamoxifen induce similar genomic interactions via co-operating factors.
  • These interactions affect ER-DNA binding and gene expression.
  • Chromatin changes provide insights into ER transcriptional regulation.

Conclusions:

  • Functional genomic methods are essential for dissecting ER-ligand and co-factor roles.
  • Combining ChIP and FAIRE offers a comprehensive approach.
  • Understanding these mechanisms advances breast cancer therapy insights.

Related Concept Videos